Hpv Vaccines Market Scope And Analysis

  • Report Code : TIPRE00029411
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 277
Buy Now

Human Papillomavirus (HPV) Vaccine Market Scope - 2031

Buy Now

Human Papillomavirus (HPV) Vaccine Market Report Human Papillomavirus (HPV) Vaccine Market Size and Share Human Papillomavirus (HPV) Vaccine Market Scope and Analysis

Human Papillomavirus (HPV) Vaccine Market Report Scope

Report Attribute Details
Market size in 2022 US$ 4.27 Billion
Market Size by 2028 US$ 5.73 Billion
Global CAGR (2022 - 2028) 5.0%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • 9-Valent HPV Vaccine
  • Quadrivalent HPV Vaccine
  • Bivalent HPV Vaccine
By Dosage
  • 2 Dose and 3 Dose
By Age
  • 9 to 14 Years and 15 to 45 Years
By Application
  • HPV-Attributable Cancer and Genital Warts
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck Co In
  • GSK
  • Serum Institute of India
  • Walvax Biotechnologies
  • Innova
  • Vaccitech
  • Innovio Pharmaceuticals
  • Chengdu Institute of Biological Products Co Ltd
  • Sanofi